Neel Ingemann Nissen

7PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2023
In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker.

Patryk J Drobinski, Neel I Nissen, Dovile Sinkeviciute

|Dec 11, 2022
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.

Emilie A Madsen, Jeppe Thorlacius-Ussing, Neel I Nissen

|Sep 23, 2022
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.

Rasmus S Pedersen, Neel I Nissen, Christina Jensen

|Apr 23, 2022
Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors.

Jeppe Thorlacius-Ussing, Christina Jensen, Emilie A Madsen

|Feb 15, 2022
Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Neel I Nissen, Astrid Z Johansen, Inna Chen

|Mar 09, 2021
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma.

Neel Ingemann Nissen, Stephanie Kehlet, Astrid Z Johansen

Pageof 2

Frequent Collaborators

4 joint publications

Inna M Chen

3 joint publications

Jeppe Thorlacius-Ussing

3 joint publications

Christina Jensen

3 joint publications

Lars N Jørgensen